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Background
The RV144 vaccine trial of canarypox vCP1521 (ALVAC-
HIV) prime and bivalent HIV-1 envelop gp120 protein
subtype B/CRF01_AE boost (AIDSVAX B/E) demon-
strated a significant effect in preventing HIV-1 infection.
A case-control analysis suggested that variable loops 1 and
2 (V2) of gp120 may have contributed to protection
against HIV-1 acquisition. Two other vaccine trials using
gp120 only– VAX003 (AIDSVAX B/E) and VAX004
(AIDSVAX B/B) failed to show protection.
Methods
Binding antibody responses induced by the RV144,
VAX003 and VAX004 vaccine regimens were compared
using ELISA. Recombinant gp120 envelope proteins MN
(subtype B), 92TH023 (CRF01_AE), A244 (CRF01_AE)
and cyclic V2 peptides were used as capture antigens.
Results
After two protein injections, VAX004 had the highest geo-
metric mean titers (GMT) against MN (25,600), VAX003
against A244 (21,378) and RV144 against 92TH023
(6,263). Antibody responses against V2 (CRF01_AE) were
detected in plasma samples from RV144 and VAX003
with GMTs of 972 and 1100, respectively. However,
VAX004 failed to generate antibodies against CRF01_AE
V2. None of the three vaccines generated antibodies
against MN V2 after two protein immunizations.
Compared to VAX004, VAX003 had higher antibody
responses against all three recombinant proteins: 2-fold
(MN), 4-fold (A244) and 4-fold (92TH023) when two
additional protein injections were administered. Two
additional protein inoculations in the VAX trials failed to
increase antibody titers against, CRF01_AE V2, but gen-
erated a small response against MN V2 (GMT, 76) in
VAX003.
Conclusion
Antibody responses against V2 were induced by CRF01_A
E recombinant proteins as there were no responses
induced by the AIDSVAX B/B vaccine regimen. Repeated
protein immunization increased the magnitude of
responses against recombinant proteins in VAX003 but
failed to increase titers against CRF01_AE V2. If antibodies
against V2 are protective against HIV-1 acquisition,
designing antigens with greater V2 antigenicity would be
critical.
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